266717 |
Amino acid sequence of human prothrombin fragments 1 and 2. |
873923 |
Primary structure of human prethrombin 2 and alpha-thrombin. |
1349838 |
Detection of a single base substitution of the gene for prothrombin Tokushima. The application of PCR-SSCP for the genetic and molecular analysis of dysprothrombinemia. |
1354985 |
Prothrombin Salakta: substitution of glutamic acid-466 by alanine reduces the fibrinogen clotting activity and the esterase activity. |
1421398 |
Prothrombin Himi: a compound heterozygote for two dysfunctional prothrombin molecules (Met-337-->Thr and Arg-388-->His). |
2369893 |
Crystal structure of the thrombin-hirudin complex: a novel mode of serine protease inhibition. |
2374926 |
The structure of a complex of recombinant hirudin and human alpha-thrombin. |
2583108 |
The refined 1.9 A crystal structure of human alpha-thrombin: interaction with D-Phe-Pro-Arg chloromethylketone and significance of the Tyr-Pro-Pro-Trp insertion segment. |
2719946 |
Substitution of valine for glycine-558 in the congenital dysthrombin thrombin Quick II alters primary substrate specificity. |
2825773 |
Nucleotide sequence of the gene for human prothrombin. |
2856554 |
Synthetic peptides bind to high-affinity thrombin receptors and modulate thrombin mitogenesis. |
3242619 |
Identification of the primary structural defect in the dysthrombin thrombin Quick I: substitution of cysteine for arginine-382. |
3567158 |
Prothrombin Tokushima, a replacement of arginine-418 by tryptophan that impairs the fibrinogen clotting activity of derived thrombin Tokushima. |
3759958 |
Prothrombin fragment 1 X 2 X 3, a major product of prothrombin activation in human plasma. |
3771562 |
Molecular defect of prothrombin Barcelona. Substitution of cysteine for arginine at residue 273. |
3801671 |
Prothrombin Tokushima: characterization of dysfunctional thrombin derived from a variant of human prothrombin. |
6305407 |
Characterization of the complementary deoxyribonucleic acid and gene coding for human prothrombin. |
6323392 |
Mechanism of inhibition of activated protein C by protein C inhibitor. |
6405779 |
Determination of the amino acid substitution in human prothrombin type 3 (157 Glu leads to Lys) and the localization of a third thrombin cleavage site. |
7792730 |
Prothrombin Frankfurt: a dysfunctional prothrombin characterized by substitution of Glu-466 by Ala. |
7865694 |
Prothrombin Padua I: incomplete activation due to an amino acid substitution at a factor Xa cleavage site. |
8071320 |
Crystallographic structure of human gamma-thrombin. |
8073540 |
Isolation and partial characterization of crystal matrix protein as a potent inhibitor of calcium oxalate crystal aggregation: evidence of activation peptide of human prothrombin. |
8251938 |
Changes in interactions in complexes of hirudin derivatives and human alpha-thrombin due to different crystal forms. |
9214615 |
The thrombin E192Q-BPTI complex reveals gross structural rearrangements: implications for the interaction with antithrombin and thrombomodulin. |
10051558 |
Unexpected crucial role of residue 225 in serine proteases. |
10391209 |
Characterization of single-nucleotide polymorphisms in coding regions of human genes. |
11493008 |
Inhibition of human alpha-thrombin by a phosphonate tripeptide proceeds via a metastable pentacoordinated phosphorus intermediate. |
11506076 |
Thrombophilic gene mutations and recurrent spontaneous abortion: prothrombin mutation increases the risk in the first trimester. |
14702039 |
Complete sequencing and characterization of 21,243 full-length human cDNAs. |
14760718 |
Screening for N-glycosylated proteins by liquid chromatography mass spectrometry. |
14962227 |
Prothrombin Shanghai: hypoprothrombinaemia caused by substitution of Gla29 by Gly. |
15489334 |
The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC). |
15534175 |
Meta-analysis of genetic studies in ischemic stroke: thirty-two genes involving approximately 18,000 cases and 58,000 controls. |
15885491 |
rhBMP-2, rhVEGF(165), rhPTN and thrombin-related peptide, TP508 induce chemotaxis of human osteoblasts and microvascular endothelial cells. |
16335952 |
Human plasma N-glycoproteome analysis by immunoaffinity subtraction, hydrazide chemistry, and mass spectrometry. |
16763681 |
Multipolar interactions in the D pocket of thrombin: large differences between tricyclic imide and lactam inhibitors. |
17244316 |
Thrombin peptide Chrysalin stimulates healing of diabetic foot ulcers in a placebo-controlled phase I/II study. |
17685615 |
Crystal structure of a biosynthetic sulfo-hirudin complexed to thrombin. |
18291642 |
Structure-based design of novel groups for use in the P1 position of thrombin inhibitor scaffolds. Part 2: N-acetamidoimidazoles. |
18362344 |
Molecular basis of thrombin recognition by protein C inhibitor revealed by the 1.6-A structure of the heparin-bridged complex. |
19139490 |
A strategy for precise and large scale identification of core fucosylated glycoproteins. |
19159218 |
Glycoproteomics analysis of human liver tissue by combination of multiple enzyme digestion and hydrazide chemistry. |
19838169 |
Enrichment of glycopeptides for glycan structure and attachment site identification. |
22028381 |
Quantitative detection of single amino acid polymorphisms by targeted proteomics. |
22171320 |
Human urinary glycoproteomics; attachment site specific analysis of N-and O-linked glycosylations by CID and ECD. |
24275569 |
An enzyme assisted RP-RPLC approach for in-depth analysis of human liver phosphoproteome. |